Hypertension: all 6,834 studies

Page 16 of 69. Open to participants first (972), then studies with results posted, then the rest; newest registration first within each.

• Nebivolol, Lifestyle Modification and Arterial StiffnessCompletedNCT01920282Phase 4Results posted
• Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and HyperlipidemiaCompletedNCT01918332Phase 3Results posted
• 11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary HypertensionCompletedNCT01917136Phase 2Results posted
• Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular HypertensionCompletedNCT01915940Phase 2Results posted
• Controlling and Lowering Blood Pressure With The MOBIUS HD™ (CALM-FIM_EUR)CompletedNCT01911897Not applicableResults posted
• Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus AmlodipineCompletedNCT01911780Phase 3Results posted
• Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart FailureTerminatedNCT01910389Phase 3Results posted
• Beraprost-314d Added-on to Tyvaso® (BEAT)CompletedNCT01908699Phase 3Results posted
• EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for HypertensionTerminatedNCT01903187Not applicableResults posted
• Etiology of Sleep Apnea-related Hyperaldosteronism - BP TreatmentCompletedNCT01897727Not applicableResults posted
• Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHTCompletedNCT01895972Phase 3Results posted
• A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)TerminatedNCT01894022Phase 3Results posted
• Ambrisentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension.TerminatedNCT01884675Phase 3Results posted
• An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular HypertensionCompletedNCT01881126Phase 4Results posted
• Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to OlmesartanCompletedNCT01876368Phase 3Results posted
• Study of the Long-term Effects of Exercise on Heath Indicators in Older PeopleCompletedNCT01874132Not applicableResults posted
• A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With HypertensionCompletedNCT01870739Phase 2Results posted
• Assessing the Impact of Calcium Channel Blockers on COGnitive Function in the Very Elderly (AI-COG)CompletedNCT01868165Results posted
• A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular HypertensionCompletedNCT01863953Phase 2Results posted
• Tadalafil for Pulmonary Hypertension Due to Chronic Lung DiseaseCompletedNCT01862536Phase 2Results posted
• Impact of Ramadan on Achieving Joint National Committee (JNC) 7 Treatment Goals in CV Risk PatientsCompletedNCT01853839Results posted
• Efficacy of Wet Cupping on Blood Pressure Among Hypertension PatientsCompletedNCT01853371Not applicableResults posted
• A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical ReasonsCompletedNCT01853085Results posted
• Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT InstrumentTerminatedNCT01847014Phase 3Results posted
• Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT InstrumentCompletedNCT01841762Phase 3Results posted
• Targeting the Right Ventricle in Pulmonary HypertensionCompletedNCT01839110Phase 4Results posted
• Controlling and Lowering Blood Pressure With The MOBIUSHD™CompletedNCT01831895Not applicableResults posted
• A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular HypertensionCompletedNCT01830140Phase 3Results posted
• A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)CompletedNCT01824290Phase 3Results posted
• Efficacy Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension (PAH)CompletedNCT01808313Phase 3Results posted
• A Non-Interventional Follow Up Study For Subjects Who Received Sildenafil for Persistent Pulmonary Hypertension of the Newborn (PPHN)CompletedNCT01801982Results posted
• Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life DepressionTerminatedNCT01794455Phase 4Results posted
• Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential HypertensionCompletedNCT01788358Phase 3Results posted
• Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential HypertensionCompletedNCT01785472Phase 3Results posted
• GAstric Bypass to Treat obEse Patients With steAdy hYpertensionCompletedNCT01784848Not applicableResults posted
• A Study of Quantitative Assessments of Angle Width in Chinese Patients With Open-angle Glaucoma and/or Ocular HypertensionTerminatedNCT01781962Results posted
• Pilot Study: Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's PreventionCompletedNCT01780974Phase 1/2Results posted
• Effect of Azilsartan on Aldosterone in Postmenopausal FemalesCompletedNCT01774591Not applicableResults posted
• Azilsartan Circadian and Sleep PressureCompletedNCT01762501Not applicableResults posted
• NSAID Effects on Clinical and Imaging Breast BiomarkersCompletedNCT01761877Phase 2Results posted
• Electronic Health Record-Based Clinical Decision Support to Improve Blood Pressure Management in AdolescentsCompletedNCT01760239Not applicableResults posted
• RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant HypertensionCompletedNCT01756300Phase 1Results posted
• A Pilot Study of Chlorthalidone Among Patients With Poorly Controlled Hypertension and CKDCompletedNCT01750294Phase 4Results posted
• Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01749930Phase 3Results posted
• Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01749904Phase 3Results posted
• An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering TreatmentsCompletedNCT01735214Results posted
• Evaluation of Hypertension as a Predictor of Efficacy Bevacizumab in Metastatic Breast Cancer and Colorectal CancerCompletedNCT01733628Results posted
• Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PHCompletedNCT01726049Phase 3Results posted
• A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The NewbornCompletedNCT01720524Phase 3Results posted
• The Effect of Sorafenib on Portal PressureCompletedNCT01714609Phase 2Results posted
• Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus ToxicityTerminatedNCT01709136Phase 2/3Results posted
• BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01707381Phase 2Results posted
• IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTensioNTerminatedNCT01705080Results posted
• Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With HypertensionCompletedNCT01692301Phase 2Results posted
• Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver DecompensationCompletedNCT01687257Phase 2Results posted
• Value of Liquid Potassium Magnesium Citrate in Controlling HypertensionCompletedNCT01682837Phase 2Results posted
• Dietary Nitrate for Heart FailureCompletedNCT01682356Phase 1/2Results posted
• Oral Nitrite in Adults With Metabolic Syndrome and HypertensionCompletedNCT01681810Phase 2Results posted
• Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive HypertensionCompletedNCT01681576Phase 2Results posted
• Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant HypertensionCompletedNCT01673373Not applicableResults posted
• Anti-hypertensive Medication Dosing Regimen in Effective Blood Pressure ControlCompletedNCT01669928Phase 4Results posted
• An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®CompletedNCT01664039Phase 4Results posted
• Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to AmlodipineCompletedNCT01663233Phase 3Results posted
• Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma PatientsCompletedNCT01658839Phase 1Results posted
• A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for HypertensionCompletedNCT01658657Not applicableResults posted
• A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8150 (MK-8150-002)CompletedNCT01656408Phase 1Results posted
• Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older PeopleCompletedNCT01650402Not applicableResults posted
• FK506 (Tacrolimus) in Pulmonary Arterial HypertensionCompletedNCT01647945Phase 2Results posted
• Translating a Heart Disease Lifestyle Intervention Into the CommunityCompletedNCT01647438Not applicableResults posted
• Safety and Tolerability and Efficacy of LCZ696 in Japanese Severe Hypertensive PatientsCompletedNCT01646671Phase 3Results posted
• Tailored Approaches to Improve Medication AdherenceCompletedNCT01643473Not applicableResults posted
• Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial HypertensionCompletedNCT01642407Phase 4Results posted
• An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal HypertensionCompletedNCT01640964Phase 2Results posted
• Study of Cardiovascular Disease and Obstructive Sleep ApneaCompletedNCT01637623Phase 2Results posted
• A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to MonotherapyCompletedNCT01637246Results posted
• Adjunctive Renal Denervation in the Treatment of Atrial FibrillationCompletedNCT01635998Not applicableResults posted
• A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT01632423Results posted
• Evaluation of the Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive SubjectsCompletedNCT01631864Phase 2Results posted
• Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential HypertensionCompletedNCT01631227Phase 3Results posted
• A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT01628614Results posted
• GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to MonotherapyCompletedNCT01628601Results posted
• Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT01628588Results posted
• Impact of Renal SympAthetic DenerVation on Chronic HypErtensionTerminatedNCT01628198Not applicableResults posted
• Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKDCompletedNCT01617681Phase 3Results posted
• Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant SuitabilityCompletedNCT01615484Not applicableResults posted
• Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential HypertensionCompletedNCT01615198Phase 3Results posted
• Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?TerminatedNCT01605370Phase 4Results posted
• Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by AmlodipineCompletedNCT01603940Phase 4Results posted
• Evaluation of Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate HypertensionCompletedNCT01601470Phase 2Results posted
• Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential HypertensionCompletedNCT01599104Phase 3Results posted
• Probiotics for Liver Cirrhosis With Portal HypertensionCompletedNCT01598064Not applicableResults posted
• A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)CompletedNCT01594970Phase 4Results posted
• Safety and Tolerability and Efficacy of LCZ696 in Japanese Hypertensive Patients With Renal DysfunctionCompletedNCT01593787Phase 3Results posted
• A Single Rising Dose Study of MK-8150 (MK-8150-001)CompletedNCT01590810Phase 1Results posted
• A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT01589510Results posted
• Remodulin® to Oral Treprostinil TransitionCompletedNCT01588405Phase 2Results posted
• PAHTCH Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure (Carvedilol)CompletedNCT01586156Not applicableResults posted
• Northwestern University and Access Community Health Network Medication Education StudyCompletedNCT01578577Not applicableResults posted
• 8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With HypertensionCompletedNCT01570686Phase 4Results posted
• Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT01568008Results posted

← Hypertension overview